Affiliated Institutions
Related Publications
The Dapagliflozin And Prevention of Adverse‐outcomes in Heart Failure (DAPA‐HF) trial: baseline characteristics
Background The aims of this study were to: (i) report the baseline characteristics of patients enrolled in the Dapagliflozin And Prevention of Adverse‐outcomes in Heart Failure ...
Prevalence of Diabetes and Impaired Fasting Glucose in Adults in the U.S. Population
OBJECTIVE—The purpose of this study was to examine the prevalences of diagnosed and undiagnosed diabetes, and impaired fasting glucose (IFG) in U.S. adults during 1999–2002, and...
Full Accounting of Diabetes and Pre-Diabetes in the U.S. Population in 1988–1994 and 2005–2006
OBJECTIVE—We examined the prevalences of diagnosed diabetes, and undiagnosed diabetes and pre-diabetes using fasting and 2-h oral glucose tolerance test values, in the U.S. duri...
Which biochemical assay is best for measuring diabetes prevalence?
Accurate assessments of diabetes prevalence are needed to allocate resources for treating patients and monitoring treatment coverage. Researchers need methods of making populati...
Sodium Glucose Cotransporter-2 Inhibition in Heart Failure
Despite current established therapy, heart failure (HF) remains a leading cause of hospitalization and mortality worldwide. Novel therapeutic targets are therefore needed to imp...
Publication Info
- Year
- 2025
- Type
- article
- Pages
- 1-20
- Citations
- 0
- Access
- Closed
External Links
Social Impact
Social media, news, blog, policy document mentions
Citation Metrics
Cite This
Identifiers
- DOI
- 10.1017/s0022215125104039